Iron‐Melanin Interaction and Lipid Peroxidation: Implications for Parkinson's Disease
- 1 November 1991
- journal article
- Published by Wiley in Journal of Neurochemistry
- Vol. 57 (5), 1609-1614
- https://doi.org/10.1111/j.1471-4159.1991.tb06358.x
Abstract
: The vulnerability of substantia mgral (SN) melaninized dopamine neurons to neurodegeneration in Parkinson's disease and the selective increases of iron and basal lipid peroxidation in SN indicate that iron-melanin interaction could be crucial to the pathogenesis of this disease. The present study describes, for the first time, the identification and characterization of a high-affinity (KD= 13 nM) and a lower affinity (KD= 200 nM) binding site for iron on dopamine melanin. The binding of iron to melanin is dependent on pH and the concentration of melanin Iron dictators, U74500A, desferrioxamme, and to less extent 1,10-phenanthroline and chlorpromazine, but not the Parkinson-inducing neurotoxin, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, can inhibit the binding of iron to melanin and iron-induced lipid peroxidation. Although melanin atone diminishes basal lipid peroxidation in rat cortical homogenates, it can also potentiate that initiated by iron, a reaction inhibited by desferrioxamine. In the absence of an identifiable exogenous or endogenous neurotoxin in idiopathic Parkinson's disease, iron-melanin interaction in pars compacta of SN may be a strong candidate for the cytotoxic component of oxygen radical-induced neurodegeneration of meianinized dopamine neurons.Keywords
This publication has 33 references indexed in Scilit:
- Lipid Peroxidation in Pigmented and Unpigmented Liver Tissues: Protective Role of MelaninPigment Cell Research, 1990
- Oxidants and the central nervous system: some fundamental questions. Is oxidant damage relevant to Parkinson's disease, Alzheimer's disease, traumatic injury or stroke?Acta Neurologica Scandinavica, 1989
- Is Parkinson's disease a progressive siderosis of substantia nigra resulting in iron and melanin induced neurodegeneration?Acta Neurologica Scandinavica, 1989
- Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's diseaseNature, 1988
- INCREASED NIGRAL IRON CONTENT IN POSTMORTEM PARKINSONIAN BRAINThe Lancet, 1987
- Monoamine Oxidase Activity and Monoamine Metabolism in Brains of Parkinsonian Patients Treated with l‐DeprenylJournal of Neurochemistry, 1986
- In Vivo Lipid Peroxidation in Rat Brain Following Intracortical Fe2+ InjectionJournal of Neurochemistry, 1984
- Possible role of neuromelanin in the pathogenesis of Parkinson's diseaseMechanisms of Ageing and Development, 1983
- Peroxidative Changes in Brain Cortical Fatty Acids and Phospholipids, as Characterized During Fe2+‐ and Ascorbic Acid‐Stimulated Lipid Peroxidation In VitroJournal of Neurochemistry, 1980
- Multiple Forms of Human Brain Mitochondrial Monoamine OxidaseNature, 1970